HIGHLIGHTS
- who: M. Isabel Veiga from the of Microbiology and Immunology, Columbia University Medical Center, Room , HHSC, West, th Street, New York, New York , have published the paper: Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS of 18/05/2016
- what: This approach has been successfully used to define the role of the resistance mediators pfcrt, k13 and pi4k7,26-28. The authors report its successful use to engineer pfmdr1 N86Y and Y184F mutations in parasite strains that express the two major CQ resistance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.